Skip to main content
Equibles
NXTC logo

NXTC · NextCure, Inc. · Proposed Sales

Track NXTC — free

Use NXTC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.07 +0.25 (+3.20%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our expectation to incur additional operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these unaudited financial statements are issued.”
View the 10-Q filed Aug 6, 2026
Market Cap
$35.79M
Shares
4.58M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1661059 CUSIP 65343E207 13F (30d) 27 filings 27 filers Visit website Investor relations